HEALIX ADVANCE™ Anchor with dual thread technology is designed to provide optimal fixation, demonstrated through high pullout strength.1 The multi-thread design enhances speed for faster anchor advancement into the bone.2


Features & Benefits

  • More Features and Options

    More Features and Options

    Dual-thread technology for both cortical and cancellous bone fixation. Available in 4.5 mm, 5.5 mm, and 6.5 mm sizes. Accommodates 2 or 3 strands of ORTHOCORD® High Strength Suture. Needles available on 5.5 mm and 6.5 mm 2-suture anchors for mini-open procedures. Available in radiolucent PEEK and BIOCRYL® RAPIDE™ Biocomposite Material designed to provide absorption and bony ingrowth at the implant site.3

  • Repair Integrity

    Repair Integrity

    Wide variety of surgical options. Torque strength that allows for insertion in a variety of bone densities.4-6 Promotes bony ingrowth at the implant site with the BR anchor option.3 Designed to provide optimal fixation demonstrated through high pullout strength.1 Cannulation to channel blood flow to surface.

  • Streamlined Anchor Insertion Procedure

    Streamlined Anchor Insertion Procedure

    Distal aiming nose for precise anchor placement and suture protection.

  • With PERMATAPE™ Suture

    With PERMATAPE™ Suture

    HEALIX ADVANCE™ Anchors are available loaded with a #2 ORTHOCORD, PERMACORD™ Suture and a PERMATAPE™ Suture – A 25% wider, yet less abrasive and bulky tape than the tested leading competitor.7

Supporting Documentation

HEALIX ADVANCE Anchor Resources


1. Data on file RR-101380-R
2. Internal report 103426879 
3. Barber FA, Dockery WD, Hrnack SA. Long-term Degradation of a poly-lactide Co-glycolide/B-Triculcium Phosphate Biocomposite Interferene Screw. Arthroscopy 2011; 27(5): 637-643
4-6. Data on file DVE-002466-DVR, DVE-002626-DVR, Lab Notebook 2012-18 on page 11
7. Internal test reports 103288856, 103313374 and 103398666 REV 1

Indication Statement

For product details such as indication, contraindication, warning and precaution please consult the IFU.